Novel Antibacterial Agents / / Fiorella Meneghetti and Daniela Barlocco.
This book was devoted to the latest advances achieved in the antibacterial field, with a focus on the recent efforts made to develop new antimicrobial agents with novel modes of action, and a perspective on future directions of this line of research. Antimicrobial resistance has become a major threa...
Saved in:
VerfasserIn: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | Basel, Switzerland : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022. |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 online resource (410 pages) :; illustrations |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993603183104498 |
---|---|
ctrlnum |
(CKB)5400000000043515 (NjHacI)995400000000043515 (EXLCZ)995400000000043515 |
collection |
bib_alma |
record_format |
marc |
spelling |
Meneghetti, Fiorella, author. Novel Antibacterial Agents / Fiorella Meneghetti and Daniela Barlocco. Basel, Switzerland : MDPI - Multidisciplinary Digital Publishing Institute, 2022. 1 online resource (410 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. This book was devoted to the latest advances achieved in the antibacterial field, with a focus on the recent efforts made to develop new antimicrobial agents with novel modes of action, and a perspective on future directions of this line of research. Antimicrobial resistance has become a major threat to global health, and the twenty-two published articles here reported put in evidence that the discovery and development of new antibiotics are extremely challenging. The antimicrobial research covers a wide area, spanning from the design of new compounds, also supported by molecular modeling techniques, their synthesis and characterization, and biological tests. In this context, the current crisis caused by the COVID-19 pandemic, but also older threats, such as the human immunodeficiency virus or the hepatitis C virus, require greater attention than ever. The research works described in this book provide an extremely useful example of the results achieved in the field of antibacterial drug development. The search for new chemical entities was approached starting from both natural and synthetic compounds and addressing different targets. In addition, recent findings were presented and discussed highlighting the strategies to fight bacterial resistance. Detailed references to the state-of-the-art can be found in this book. We strongly encourage the wide group of readers to explore the book that we are presenting, to get inspired to develop new approaches for the diagnosis and treatment of antibacterial diseases, and to circumvent resistance issues. Antibacterial agents. 3-0365-2861-X Barlocco, Daniela, author. |
language |
English |
format |
eBook |
author |
Meneghetti, Fiorella, Barlocco, Daniela, |
spellingShingle |
Meneghetti, Fiorella, Barlocco, Daniela, Novel Antibacterial Agents / |
author_facet |
Meneghetti, Fiorella, Barlocco, Daniela, Barlocco, Daniela, |
author_variant |
f m fm d b db |
author_role |
VerfasserIn VerfasserIn |
author2 |
Barlocco, Daniela, |
author2_role |
TeilnehmendeR |
author_sort |
Meneghetti, Fiorella, |
title |
Novel Antibacterial Agents / |
title_full |
Novel Antibacterial Agents / Fiorella Meneghetti and Daniela Barlocco. |
title_fullStr |
Novel Antibacterial Agents / Fiorella Meneghetti and Daniela Barlocco. |
title_full_unstemmed |
Novel Antibacterial Agents / Fiorella Meneghetti and Daniela Barlocco. |
title_auth |
Novel Antibacterial Agents / |
title_new |
Novel Antibacterial Agents / |
title_sort |
novel antibacterial agents / |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2022 |
physical |
1 online resource (410 pages) : illustrations |
isbn |
3-0365-2861-X |
callnumber-first |
R - Medicine |
callnumber-subject |
RM - Therapeutics and Pharmacology |
callnumber-label |
RM409 |
callnumber-sort |
RM 3409 M464 42022 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.92061 |
dewey-sort |
3616.92061 |
dewey-raw |
616.92061 |
dewey-search |
616.92061 |
work_keys_str_mv |
AT meneghettifiorella novelantibacterialagents AT barloccodaniela novelantibacterialagents |
status_str |
n |
ids_txt_mv |
(CKB)5400000000043515 (NjHacI)995400000000043515 (EXLCZ)995400000000043515 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Novel Antibacterial Agents / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796653217886502912 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02563nam a2200289 i 4500</leader><controlfield tag="001">993603183104498</controlfield><controlfield tag="005">20230623142149.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230623s2022 sz a o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000043515</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000043515</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000043515</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM409</subfield><subfield code="b">.M464 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.92061</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Meneghetti, Fiorella,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Novel Antibacterial Agents /</subfield><subfield code="c">Fiorella Meneghetti and Daniela Barlocco.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel, Switzerland :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (410 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book was devoted to the latest advances achieved in the antibacterial field, with a focus on the recent efforts made to develop new antimicrobial agents with novel modes of action, and a perspective on future directions of this line of research. Antimicrobial resistance has become a major threat to global health, and the twenty-two published articles here reported put in evidence that the discovery and development of new antibiotics are extremely challenging. The antimicrobial research covers a wide area, spanning from the design of new compounds, also supported by molecular modeling techniques, their synthesis and characterization, and biological tests. In this context, the current crisis caused by the COVID-19 pandemic, but also older threats, such as the human immunodeficiency virus or the hepatitis C virus, require greater attention than ever. The research works described in this book provide an extremely useful example of the results achieved in the field of antibacterial drug development. The search for new chemical entities was approached starting from both natural and synthetic compounds and addressing different targets. In addition, recent findings were presented and discussed highlighting the strategies to fight bacterial resistance. Detailed references to the state-of-the-art can be found in this book. We strongly encourage the wide group of readers to explore the book that we are presenting, to get inspired to develop new approaches for the diagnosis and treatment of antibacterial diseases, and to circumvent resistance issues.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Antibacterial agents.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2861-X</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barlocco, Daniela,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-06 03:25:56 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337976160004498&Force_direct=true</subfield><subfield code="Z">5337976160004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337976160004498</subfield></datafield></record></collection> |